Trial record 2 of 626 for:    secure

Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT01952119
First received: September 24, 2013
Last updated: NA
Last verified: September 2013
History: No changes posted
  Purpose

This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.


Condition Intervention
Hypertension
Other: Secure message reminder

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care Delivery System

Resource links provided by NLM:


Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • Appointment with new blood pressure reading [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
    Percentage of patients who complete an appointment with a new documented blood pressure reading within six weeks after distributing the secure message reminder


Secondary Outcome Measures:
  • New appointment with new blood pressure reading [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
  • Existing appointment kept with new blood pressure reading [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]
  • Change in antihypertensive regimen [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]

Enrollment: 182
Study Start Date: October 2011
Study Completion Date: June 2012
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Routine Care
Routine care, no intervention
Active Comparator: Secure message reminder
Will receive a secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure
Other: Secure message reminder
Single secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure

Detailed Description:

Hypertension is one of the leading risk factors for cardiovascular disease. Optimizing blood pressure management can help prevent adverse cardiovascular outcomes. The National Committee for Quality Assurance (NCQA) defines blood pressure control as less than 140/90 mmHg. Per this definition, less than half of Americans with hypertension are considered controlled. Literature has been published describing several ways of improving blood pressure management, but results have been variable.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Member of Kaiser Permanente Georgia Pharmacy Cardiac Risk Service (PCRS)
  • 18-75 years of age
  • Enrolled in http://kp.org
  • Most recent documented blood pressure is greater than or equal to 140/90 mmHg

Exclusion Criteria:

  • Most recent documented blood pressure is greater than or equal to 180/110 mmHg
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01952119

Locations
United States, Georgia
Kaiser Permanente Georgia
Atlanta, Georgia, United States, 30305
Sponsors and Collaborators
Kaiser Permanente
Investigators
Principal Investigator: Alina Kuo, PharmD Kaiser Permanente Georgia
  More Information

Publications:
Responsible Party: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT01952119     History of Changes
Other Study ID Numbers: GA-11AKuo-01
Study First Received: September 24, 2013
Last Updated: September 24, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Kaiser Permanente:
hypertension

Additional relevant MeSH terms:
Hypertension
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 21, 2015